MedPath

A study to compare between two combination of drugs dexmedetomidine and ropivacaine with budesonide and ropivacaine to check incidence of post operative sore throat after general anaesthesia.

Recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2022/12/048256
Lead Sponsor
Harsh
Brief Summary

It is a prospective double blind trial to check the efficacy of two combination of drugs i.e. Ropivacaine and dexmedetomidine with ropivacaine and budesonide in incidence and severity of post operative sore throat after general anaesthesia. The mode of giving this combination of drug is Intratracheal just prior to intubation followed by preoxygenation and then intubating under direct laryngoscopy.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
130
Inclusion Criteria
  • Patient of ASA 1 and ASA2 physical status 2.
  • Patient between 18-65 years of age.
  • Patient posted for major surgeries under General anaesthesia.
  • Patient wiling to participate.
Exclusion Criteria
  • Patient refusal to participate.
  • Patient with ASA physical status III or above.
  • Patient aged less than 18 years and more than 65 years.
  • Patient with suspected difficult airway and Mallampati grade III or above.
  • Patient with pregnancy, morbid obesity and history of sore throat.
  • Patient transferred to ICU intubated after operation under general anaesthesia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Post operative sore throat, pain on deglutition, hoarseness and coughZero Hour(Just after Extubation, 2,4,6,12,24 hrs post extubation
Secondary Outcome Measures
NameTimeMethod
Intraoperative hemodynamics changes in heart rate, blood pressure, MAP, oxygen saturationBefore giving drug, before intubation, after intubation, after 15 min of surgery, after 30 minute of surgery, after Extubation

Trial Locations

Locations (1)

Indira Gandhi Institute of Medical Science

🇮🇳

Patna, BIHAR, India

Indira Gandhi Institute of Medical Science
🇮🇳Patna, BIHAR, India
Harsh
Principal investigator
9470840038
DRHARSHPATNA@GMAIL.COM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.